Providence Capital Advisors, LLC Pfizer Inc Transaction History

Providence Capital Advisors, LLC

$487 Million
Q3 2024

A detailed history of Providence Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 113,949 shares of PFE stock, worth $2.87 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

113,949

Previous 113,143 0.71%

Holding current value

$2.87 Million

Previous $3.17 Million 4.17%

% of portfolio

0.68%

Previous 0.71%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $22,326 - $25,300	806 Added 0.71%	113,949 $3.3 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $46,857 - $54,908	1,855 Added 1.67%	113,143 $3.17 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $640,570 - $735,579	24,742 Added 28.59%	111,288 $3.09 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $2.07 Million - $2.42 Million	-64,466 Reduced 42.69%	86,546 $2.87 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $32,507 - $37,611	900 Added 0.6%	151,012 $5.54 Million
Q1 2023 May 17, 2023	SELL	$39.39 - $51.28 $235 Million - $306 Million	-5,974,479 Reduced 97.55%	150,112 $6.12 Million
Q1 2023 May 17, 2023	BUY	$39.39 - $51.28 $241 Million - $314 Million	6,124,584 Added 0.0%	6,124,591 $250 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $5.79 Million - $7.54 Million	-146,957 Reduced 100.0%	7 $0
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $50,726 - $66,217	1,215 Added 0.83%	146,964 $7.53 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $15,753 - $19,231	360 Added 0.25%	145,749 $6.38 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $761,137 - $902,470	-16,358 Reduced 10.11%	145,389 $7.62 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $503,067 - $623,363	10,996 Added 7.29%	161,747 $8.37 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $327,006 - $484,732	-7,914 Reduced 4.99%	150,751 $8.9 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $391,989 - $503,544	9,987 Added 6.72%	158,665 $6.82 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $146,440 - $165,893	4,078 Added 2.82%	148,678 $5.82 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $29,705 - $33,501	-887 Reduced 0.61%	144,600 $5.24 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $583,214 - $741,608	17,425 Added 13.61%	145,487 $5.36 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $10,572 - $12,404	333 Added 0.26%	128,062 $4.7 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $66,203 - $80,314	-2,198 Reduced 1.69%	127,729 $4.18 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $1 Million - $1.43 Million	37,142 Added 40.03%	129,927 $4.24 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $33,611 - $38,144	1,021 Added 1.11%	92,785 $3.64 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $462,007 - $599,088	14,220 Added 18.34%	91,764 $3.3 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $83,094 - $93,295	2,247 Added 2.98%	77,544 $3.36 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $57,600 - $63,283	1,536 Added 2.08%	75,297 $3.2 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $380,083 - $433,336	-9,880 Reduced 11.81%	73,761 $3.22 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $412,605 - $500,465	-11,970 Reduced 12.52%	83,641 $3.69 Million
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $114,143 - $121,688	3,461 Added 3.76%	95,611 $3.47 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $158,879 - $184,322	4,979 Added 5.71%	92,150 $3.27 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $2.9 Million - $3.08 Million	87,171	87,171 $3.16 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $142B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Pfizer Inc Transaction History